Sign up to save your podcasts
Or
Share COR2ED - Rare Diseases Medical Conversation
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
COR2ED - Rare Diseases Medical Conversation
COR2ED - Rare Diseases Medical Conversation episodes
- Rare bone disease: Highlights from ASBMR 2021. Part 4
We have partnered with international experts to provide rare bone disease highlights from ASBMR 2021.
This is the final episode in a series of four podcasts, in this episode Dr Eekhoff and Dr Rush discuss their rare bone disease highlights from the meeting.
15 min - Rare bone disease: Highlights from ASBMR 2021. Part 3
We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021.
This is the third episode in a series of four podcasts. In this episode Charlene Waldman (RBD Alliance) and Inês Alves (European Rare Bone Forum) discuss their highlights.
21 min - Rare bone disease: Highlights from ASBMR 2021. Part 2
We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021.
This is the second in a series of four podcasts. In this episode Dr Oliver Semler has selected and discusses his highlights.
17 min - Rare bone disease: Highlights from ASBMR 2021. Part 1
We have partnered with international experts to provide rare bone disease highlights from ASBMR 2021.
This is the first episode in a series of four podcasts, in this episode Dr Mughal and Dr Javaid discuss their highlights.
21 min
About COR2ED - Rare Diseases Medical Conversation
From the publisher's feed
Join medical experts as they discuss their approaches to identifying, treating, and managing rare diseases, like primary biliary cholangitis, neuroendocrine tumours, rare bone diseases, and growth disorders. The conversations also explore the evolving treatment landscape, including exciting innovations in gene therapies and the use of somatostatin analogues.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com